SEC Form 4 · accession 0000874015-15-000044
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elizabeth L Hougen
Officer — SVP, Finance & CFO
Period of report
Mar 19, 2015
Accepted (ET)
Mar 20, 2015 · 6:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 19, 2015 | M | 10,000 | $11.27 | A | 13,387 | D | |
| Common StockF1 | Mar 19, 2015 | S | 10,000 | $73.326 | D | 3,387 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $11.27 | Mar 19, 2015 | M | 10,000 | D | Jan 4, 2014 | Jan 3, 2017 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 2/3/2015.